Dynamic Calmodulin Regulation of Na Channels

Na 通道的动态钙调蛋白调节

基本信息

  • 批准号:
    8217079
  • 负责人:
  • 金额:
    $ 39.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-02-01 至 2015-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Calmodulin (CaM) regulation of four-domain channels first emerged in CaV channels, and has proved rich both mechanistically and biologically. Our laboratory has been one of the leaders in unveiling this exciting chapter of CaV channel discovery. Given the sequence similarity of CaV and NaV channels, intriguing suspicions arose that NaV channels might also exhibit such CaM regulation. This possibility was most attractive, given the wide-ranging biological and clinical impact of NaV channels, which include mentation (epilepsy), muscle contraction (myotonia and arrhythmias), and sensation (neuropathic pain). Biochemistry and structural biology both underscored this similarity, but the reported functional effects of Ca2+ and/or CaM on NaV channels have been rather subtle, mostly limited to several-mV shifts of steady-state inactivation (h%) curves. Yet, channelopathic NaV mutations at putative structural determinants of Ca2+ and/or CaM regulation do confer severe disease phenotypes. One potential culprit for the apparent disconnect is that, unlike CaV channels, NaV channels do not conduct Ca2+, so they cannot directly trigger Ca2+ responses. Instead, the NaV field has used whole-cell dialysis to tonically manipulate Ca2+ levels, over several minutes or longer. Could the field be characterizing desensitized responses to Ca2+ and/or CaM, with poor similarity to short-term and larger physiological effects? Here, we use a different approach to dynamically perturb Ca2+, and our preliminary data unveil something long sought in the field>rapid and robust Ca2+/CaM-dependent inactivation of NaV channels (CDI). The advances now permitted may revolutionize understanding of the CaM regulation of NaV channels. This project will usher in an exciting era of discovery via three specific aims. (1) To unveil the existence of rapid Ca2+/CaM-mediated regulation across the family of NaV channels. (2) To elucidate the mechanism of dynamic CaM-mediated regulation of NaV channels. With long-sought robust readouts of NaV regulation in hand, Aim 2 will be uniquely poised to dissect the mechanistic underpinnings of regulation. (3) To assess the broader biological impact of CaM-mediated regulation of Nav channels. The mechanistic advances above hold numerous biological implications that Aim 3 will explore. In all, this project will facilitate a period of unprecedented progress in the Ca2+ regulation of NaV channels. As well, this proposal will explicitly link Ca2+ regulation of NaV channels to certain channelopathies, and perhaps to related but more generalized forms of disease. PUBLIC HEALTH RELEVANCE: Ca2+ and/or calmodulin regulation of voltage-gated Na channels is poised to impact diverse aspects of physiology, as well as diseases like epilepsy/seizure, muscle myotonia/arrhythmia, and neuropathic pain. Yet, the severe disease phenotypes relating to Na channels seem incongruous with the subtle functional effects of Ca2+ and/or calmodulin seen when Na channels are intentionally studied in isolation. This proposal likely overcomes a flaw in the way isolated Na channels have been studied thus far, thereby revealing the full-bodied effects of Ca2+ regulation on Na channels, and unlocking an era of rapid advance in linking Na channel regulation to biology, disease, and potentially therapy.
说明(申请人提供):钙调蛋白(CaM)对四结构域通道的调节最先出现在Cav通道中,并被证明在机制和生物学上都很丰富。我们的实验室一直是揭开CAV频道发现这一激动人心篇章的领导者之一。鉴于CAV和NAV通道的序列相似性,出现了耐人寻味的怀疑,NAV通道可能也表现出这种CaM调节。考虑到NAV通道的广泛生物学和临床影响,包括镇静(癫痫)、肌肉收缩(肌强直和心律失常)和感觉(神经病理性疼痛),这种可能性最具吸引力。生物化学和结构生物学都强调了这种相似性,但已报道的Ca~(2+)和/或CaM对NAV通道的功能影响相当微妙,主要限于稳态失活(h%)曲线的几个mV位移。然而,在钙离子和/或CaM调节的假定结构决定因素上的通道病态NAV突变确实赋予了严重的疾病表型。造成这种明显脱节的一个潜在原因是,与Cav通道不同,NAV通道不传导钙离子,因此它们不能直接触发钙离子反应。取而代之的是,NAV领域使用全细胞透析来调节钙离子水平,持续几分钟或更长时间。磁场是否表现出对钙离子和/或钙调素的不敏感反应,与短期和更大的生理效应没有什么相似之处?在这里,我们使用一种不同的方法来动态干扰钙离子,我们的初步数据揭示了该领域长期寻求的一种现象&快速而强大的依赖钙/钙调素的NAV通道失活(CDI)。现在允许的进展可能会彻底改变人们对钙调素调节NAV通道的理解。该项目将通过三个具体目标开启一个令人兴奋的发现时代。(1)揭示钙/钙调素介导的跨NAV通道家族快速调节的存在。(2)阐明钙调素对NAV通道的动态调节机制。随着长期寻求的资产净值监管读数的强劲出炉,Aim 2将独一无二地准备好剖析监管的机制基础。(3)评估CaM介导的NAV通道调节的更广泛的生物学影响。上述机制上的进展具有许多生物学意义,目标3将对此进行探索。总而言之,该项目将促进NAV通道的钙离子调节取得前所未有的进展。此外,这一建议将明确地将NAV通道的钙调节与某些通道病联系起来,或许还与相关的、但更普遍的疾病有关。 与公共健康相关:钙离子和/或钙调素对电压门控钠通道的调节可能会影响生理的各个方面,以及癫痫/癫痫、肌肉强直/心律失常和神经病理性疼痛等疾病。然而,与钠通道相关的严重疾病表型似乎与有意孤立研究钠通道时看到的钙离子和/或钙调蛋白的微妙功能效应不一致。这一建议可能克服了迄今为止研究分离钠通道的方法中的一个缺陷,从而揭示了钙离子调节对钠通道的全面影响,并开启了将钠通道调节与生物学、疾病和潜在治疗联系起来的快速发展时代。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID T YUE其他文献

DAVID T YUE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID T YUE', 18)}}的其他基金

Chemical biological dissection of Ca2+ entry through Ca2+ channels
Ca2+通过Ca2+通道进入的化学生物学解剖
  • 批准号:
    8609908
  • 财政年份:
    2013
  • 资助金额:
    $ 39.89万
  • 项目类别:
Modulators of CaV1.3 Ca2+ regulation
CaV1.3 Ca2 调节的调节剂
  • 批准号:
    8542901
  • 财政年份:
    2012
  • 资助金额:
    $ 39.89万
  • 项目类别:
Modulators of CaV1.3 Ca2+ regulation
CaV1.3 Ca2 调节的调节剂
  • 批准号:
    8408867
  • 财政年份:
    2012
  • 资助金额:
    $ 39.89万
  • 项目类别:
Dynamic Calmodulin Regulation of Na Channels
Na 通道的动态钙调蛋白调节
  • 批准号:
    8417000
  • 财政年份:
    2011
  • 资助金额:
    $ 39.89万
  • 项目类别:
Dynamic Calmodulin Regulation of Na Channels
Na 通道的动态钙调蛋白调节
  • 批准号:
    8087233
  • 财政年份:
    2011
  • 资助金额:
    $ 39.89万
  • 项目类别:
Dynamic Calmodulin Regulation of Na Channels
Na 通道的动态钙调蛋白调节
  • 批准号:
    8604637
  • 财政年份:
    2011
  • 资助金额:
    $ 39.89万
  • 项目类别:
Ca Regulation of Ca Channels
Ca 通道的 Ca 调节
  • 批准号:
    8101126
  • 财政年份:
    2007
  • 资助金额:
    $ 39.89万
  • 项目类别:
Ca Regulation of Ca Channels
Ca 通道的 Ca 调节
  • 批准号:
    7886484
  • 财政年份:
    2007
  • 资助金额:
    $ 39.89万
  • 项目类别:
Ca Regulation of Ca Channels
Ca 通道的 Ca 调节
  • 批准号:
    7265541
  • 财政年份:
    2007
  • 资助金额:
    $ 39.89万
  • 项目类别:
Ca Regulation of Ca Channels
Ca 通道的 Ca 调节
  • 批准号:
    7649250
  • 财政年份:
    2007
  • 资助金额:
    $ 39.89万
  • 项目类别:

相似海外基金

DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
  • 批准号:
    495592
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
  • 批准号:
    23K14885
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
  • 批准号:
    10668025
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
  • 批准号:
    23K09597
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
  • 批准号:
    514892030
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
    WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
  • 批准号:
    10638497
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
  • 批准号:
    10722857
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
  • 批准号:
    10724935
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
  • 批准号:
    10727929
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 39.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了